2Jemal A,Clegg LX,Ward E,et al. Annual report to the nation on the status of cancer, 1975 -2001, with a special feature regarding survival[J].Cancer, 2004,101 (1) : 23-27.
3Pfister C,Chautard D,Devonec M,et al. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study[J]. J Urol, 2003,169 ( 3 ) : 921-924.
4El-Assal ON, Yamanoi A, Ono T, et al. The clinicopathological significance of heparanase and basic fibroblast growth factor ex pressions in hepatocellular carcinoma[J]. Clin Cancer Res, 2001,7 (5) : 1299-1305.
5Stavropoulos NE,Filliadis I,loaehim E,et ah CD44 stanclara Iorm expression as a predictor of progression in high risk superficial bladder tumors[J].Jnt Urol Nephrol,2001,33(3) :479-483.
6Ishida T. Immunohistochemical expression of the CD44 variant 6 in coloreetal adenocarcinoma[J]. Surg Today, 2000,80 (1) : 28-32.
7Li CZ, Liu B, Wen ZQ, et al. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian Cancer cells in vitro and in vivo[J]. Folia Biol (Krakow), 2008,54(6) :180- 186.
8Washino S, Hirai M, Matsuzaki A, et al. Clinical usefulness of CEA,CA19 9,and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma[J]. Urol Int,2011,87(4) :420 -428.
9Hegele A, Mecklenburg V, Varga Z, et al. CA19-9 and CEA in transitiomd cell carcinoma of the bladder:serological and immuno- histochemical findings[J]. Anticancer Res, 2010, 30 ( 12) : 5195 -5200.
10Woodman AC,Sugiyama M,Yoshida K,et al. Analysis of anoma lous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms [J]. Am J Pathol,1996,149(5) :1519-1530.
